FLIPS/L siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemFLIPS/L siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-35388
Quantity10 µM
Gene NameCASP8 and FADD-like apoptosis regulator
Specieshuman
TypesiRNA/dsRNA
NCBI Full Gene NameCASP8 and FADD like apoptosis regulator
NCBI Gene AliasesCASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS, cFLIP

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Overexpression of miR-382 Sensitizes Hepatocellular Carcinoma Cells to γδ T Cells by Inhibiting the Expression of c-FLIPMolecular therapy oncolyticsSeptember 25, 2020Chen Z, Zheng Z, Feng L, Huo Z, Huang L, Fu M, Chen Q, Ke Y, Yang J, Hou B.

(2) CFLAR is a critical regulator of cerebral ischaemia-reperfusion injury through regulating inflammation and endoplasmic reticulum (ER) stressBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieSeptember 1, 2019Xiaohong W, Jun Z, Hongmei G, Fan Q.

(3) Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer ModelsCancersJune 26, 2019Mahalingam D, Carew JS, Espitia CM, Cool RH, Giles FJ, de Jong S, Nawrocki ST.

(4) AKT activator SC79 protects hepatocytes from TNF-α-mediated apoptosis and alleviates d-Gal/LPS-induced liver injuryAmerican journal of physiology. Gastrointestinal and liver physiologyMarch 1, 2019Jing ZT, Liu W, Xue CR, Wu SX, Chen WN, Lin XJ, Lin X.siRNA, sc-29410; Santa Cruz Biotechnology, Santa Cruz, CA), 80 nM siRNAs against FLIP gene (FLIPL/S siRNA, sc-35388; Santa Cruz Biotechnology) and a control siRNA that did not target any human gene (sc-37007; Santa Cruz Biotechnology

(5) Codium fragile F2 sensitize colorectal cancer cells to TRAIL-induced apoptosis via c-FLIP ubiquitinationBiochemical and biophysical research communicationsJanuary 1, 2019Park SH, Kim JL, Jeong S, Kim BR, Na YJ, Jo MJ, Yun HK, Jeong YA, Kim DY, Kim BG, et al.

(6) Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulationMolecular medicine reportsJanuary 1, 2015Luan Z, He Y, He F, Chen Z.

(7) β-Elemene piperazine derivatives induce apoptosis in human leukemia cells through downregulation of c-FLIP and generation of ROSPloS oneJanuary 25, 2011Yu Z, Wang R, Xu L, Xie S, Dong J, Jing Y.lysate were determined by the Bradford protein binding assay [9]. RNA interference FLIPS/L siRNA (sc-35388) and a negative control siRNA (sc-37007) were purchased from Santa Cruz Biotechnology, Inc. siRNA was

(8) Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1PLoS pathogensApril 15, 2010Melki MT, Saïdi H, Dufour A, Olivo-Marin JC, Gougeon ML.

(9) Scatter factor protects tumor cells against apoptosis caused by TRAILAnti-cancer drugsJanuary 1, 2010Fan S, Meng Q, Laterra JJ, Rosen EM.

(10) High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-ImidazolideCancer lettersSeptember 18, 2009Petronelli A, Saulle E, Pasquini L, Petrucci E, Mariani G, Biffoni M, Ferretti G, Scambia G, Benedetti-Panici P, Greggi S, et al.

(11) The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activationEur J CancerSeptember 1, 2009Carlisi D, Lauricella M, D'Anneo A, Emanuele S, Angileri L, Di Fazio P, Santulli A, Vento R, Tesoriere G.

(12) Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cellsCancer researchFebruary 1, 2009Murtaza I, Saleem M, Adhami VM, Hafeez BB, Mukhtar H.

(13) Sodium butyrate sensitizes human colon adenocarcinoma COLO 205 cells to both intrinsic and TNF-alpha-dependent extrinsic apoptosisApoptosis : an international journal on programmed cell deathFebruary 1, 2009Pajak B, Gajkowska B, Orzechowski A.

(14) PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancerJournal of cellular and molecular medicineDecember 1, 2008Zanca C, Garofalo M, Quintavalle C, Romano G, Acunzo M, Ragno P, Montuori N, Incoronato M, Tornillo L, Baumhoer D, et al.Carlsbad, CA, USA) (UCACUAUGGUGGUUGACUATT), c-FLIP siRNA was purchased from Santa Cruz Biotechnology, Inc. (sc-35388). siCONTROL Non-Targeting siRNA Pool #2 (D-001206-14-05) was from Dhamarcon (Lafayette, CO, USA) and

(15) Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cellsOral oncologyApril 1, 2008Iwase M, Takaoka S, Uchida M, Yoshiba S, Kondo G, Watanabe H, Ohashi M, Nagumo M.

(16) Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cellsInternational journal of cancerSeptember 15, 2007Lane D, Robert V, Grondin R, Rancourt C, Piché A.

(17) Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosisApoptosis : an international journal on programmed cell deathApril 1, 2007Saulle E, Petronelli A, Pasquini L, Petrucci E, Mariani G, Biffoni M, Ferretti G, Scambia G, Benedetti-Panici P, Cognetti F, et al.

(18) FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosisLaboratory investigation; a journal of technical methods and pathologyJuly 1, 2005Dolcet X, Llobet D, Pallares J, Rue M, Comella JX, Matias-Guiu X.

Be the First to Write a Review!

FLIPS/L siRNA (h)

FLIPS/L siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (18)

Reviews

FLIPS/L siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map